SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-19-001346
Filing Date
2019-02-28
Accepted
2019-02-28 17:04:41
Documents
101
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tbph-20181231x10k.htm 10-K 3550727
2 EX-21.1 tbph-20181231ex211a2244a.htm EX-21.1 3109
3 EX-23.1 tbph-20181231ex231b45b1d.htm EX-23.1 4164
4 EX-31.1 tbph-20181231ex311c99c67.htm EX-31.1 10677
5 EX-31.2 tbph-20181231ex3120634ab.htm EX-31.2 10824
6 EX-32 tbph-20181231xex32.htm EX-32 18685
7 GRAPHIC tbph20181231x10k001.jpg GRAPHIC 58226
  Complete submission text file 0001558370-19-001346.txt   12609156

Data Files

Seq Description Document Type Size
8 EX-101.INS tbph-20181231.xml EX-101.INS 2736395
9 EX-101.SCH tbph-20181231.xsd EX-101.SCH 76394
10 EX-101.CAL tbph-20181231_cal.xml EX-101.CAL 70962
11 EX-101.DEF tbph-20181231_def.xml EX-101.DEF 350979
12 EX-101.LAB tbph-20181231_lab.xml EX-101.LAB 694739
13 EX-101.PRE tbph-20181231_pre.xml EX-101.PRE 589298
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36033 | Film No.: 19644598
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences